1 / 3

Chronic Obstructive Pulmonary Disease Market Procedures and Research Methodology by 2025

Chronic obstructive pulmonary disease (COPD), also known as chronic obstructive lung disease (COLD), is a condition characterized by difficulty in breathing, shortness of breath, wheezing, chest tightness, and other respiratory symptoms that progress over time.

priyanks0607
Download Presentation

Chronic Obstructive Pulmonary Disease Market Procedures and Research Methodology by 2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Chronic Obstructive Pulmonary Disease Market Procedures and Research Methodology by 2025 “Chronic obstructive pulmonary disease (COPD), also known as chronic obstructive lung disease (COLD), is a condition characterized by difficulty in breathing, shortness of breath, wheezing, chest tightness, and other respiratory symptoms that progress over time.” Chronic obstructive pulmonary disease (COPD), also known as chronic obstructive lung disease (COLD), is a condition characterized by difficulty in breathing, shortness of breath, wheezing, chest tightness, and other respiratory symptoms that progress over time. The disease is often caused by tobacco smoking; however, long-term exposure to other lung irritants, such as smoke from vehicle emissions and power stations, chemical fumes, and dust from the environment and workplace, can also contribute to the development. To forecast the total prevalent cases of COPD and the diagnosed prevalent cases of COPD in the 8MM, epidemiologists used studies published in peer-reviewed journals that provided the ageand sex-specific total and diagnosed prevalent cases of COPD in the respective markets. In the 8MM, epidemiologists forecast that the total prevalent cases of COPD will increase from 65,991,432 cases in 2015 to 76,066,482 cases in 2025 at an Annual Growth Rate (AGR) of 1.53%. In the 8MM, epidemiologists forecast that the diagnosed prevalent cases of COPD will increase from 24,482,101 cases in 2015 to 27,924,212 cases in 2025 at an AGR of 1.41%. The US had the highest number of total and diagnosed prevalent cases of COPD in the 8MM. Browse Detail Report With TOC @ http://www.hexareports.com/report/epicast-report-chronic- obstructive-pulmonary-disease-epidemiology-forecasts-to-2025 Follow Us:

  2. Scope The Chronic obstructive pulmonary disease (COPD) EpiCast Report provides an overview of the risk factors and global trends of COPD in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and Australia). It includes a 10-year epidemiological forecast for the total prevalent cases of COPD (diagnosed and undiagnosed cases) and the diagnosed prevalent cases of COPD, which are segmented by sex and age (35-44, 45-54, 55-64, 65-74, and 75 years and older). The diagnosed prevalent cases of COPD are further segmented by the new GOLD 2011 severity stage (GOLD A, GOLD B, GOLD C, and GOLD D) using the COPD Assessment Test (CAT) scores and the modified Medical Research Council (mMRC) dyspnea scores. The COPD epidemiology report is written and developed by Mastersand PhD-level epidemiologists. The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM. Request A Sample copy of This Report @ http://www.hexareports.com/report/epicast-report- chronic-obstructive-pulmonary-disease-epidemiology-forecasts-to-2025/request-sample Reasons To Buy 1.Develop business strategies by understanding the trends shaping and driving the global COPD market. 2.Quantify patient populations in the global COPD market to improve product design, pricing, and launch plans. 3.Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for COPD therapeutics in each of the markets covered. 4.Understand severity stages of COPD cases by CAT score and mMRC scores. Browse More Pharmaceuticals & Healthcare Related Market Research Reports: • EpiCast Report: Hemophilia - Epidemiology Forecast to 2026 - http://www.hexareports.com/report/epicast-report-hemophilia-epidemiology-forecast-to-2026 • EpiCast Report: Heart Failure - Epidemiology Forecasts to 2026 - http://www.hexareports.com/report/epicast-report-heart-failure-epidemiology-forecasts-to-2026 • Chlamydia Infections Global Clinical Trials Review, H1, 2017 - http://www.hexareports.com/report/chlamydia-infections-global-clinical-trials-review-h1-2017 Follow Us:

  3. About Us: Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Information: Ryan Shaw Felton Office Plaza, 6265 Highway 9, Felton, California, 95018, United States Phone Number 1-800-489-3075 Email Us: sales@hexareports.com Our Website: http://www.hexareports.com/ Follow Us:

More Related